TQB2450 Solution for Injection (TQB2450)+Paclitaxel+Cisplatin ± Anlotinib

See also
Status	Clinical Trial	Phase
Completed	`NCT02128243` - Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer	Phase 2
Completed	`NCT02253602` - Innovative MRI Techniques to Improve Treatment Stratification of Patients With Esophageal Cancer	N/A
Completed	`NCT01900691` - Removal of the Evolution® Esophageal Stent - Fully Covered	N/A
Completed	`NCT01719926` - Phase I Platinum Based Chemotherapy Plus Indomethacin	Phase 1
Terminated	`NCT01572987` - Endoscopic Resection or Ablation for Patients With Dysplasia or Cancer Requiring Treatment of Barrett's Esophagus	N/A
Terminated	`NCT00760604` - A Phase III Study of En Bloc Versus Non-En Bloc Esophagectomy in Esophageal Cancer	Phase 3
Completed	`NCT00160030` - Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in Patients With Inoperable Esophageal Cancer	Phase 2
Suspended	`NCT00048529` - Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the Esophagus	Phase 2
Recruiting	`NCT05007106` - MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)	Phase 2
Completed	`NCT02284802` - Early Detection of Tumors of the Digestive Tract by Confocal Endomicroscopy	N/A
Terminated	`NCT03223662` - Metabolomic and BH3 Profiling of Esophageal Cancers: Identification of Novel Assessment Methods of Treatment Response for Precision Therapy	Phase 2
Completed	`NCT05680077` - KCNA3 and OTOP2 Gene Methylation Combined Detection Kit (Fluorescent PCR Method)
Completed	`NCT03549494` - Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction	Phase 2
Completed	`NCT03261947` - A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors	Phase 2
Terminated	`NCT00094978` - Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum	Phase 1
Recruiting	`NCT02908204` - Long-term Outcomes of Superficial Esophageal Squamous Cell Carcinoma	N/A
Completed	`NCT02378948` - Nutritional Route In Esophageal Resection Trial II	N/A
Completed	`NCT02703142` - Endoscopic Evaluation After Esophagectomy	N/A
Recruiting	`NCT02604615` - The Role of Different Cycles of Chemotherapy（Capecitabine-oxaliplatin） in Esophageal Chemoradiotherapy	Phase 3
Active, not recruiting	`NCT02279134` - Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma	Phase 2/Phase 3

NCT number	NCT05013697
Study type	Interventional
Source	Henan Cancer Hospital
Contact	Suxia Luo, Doctor
Phone	0371-65587697
Email	2290773710@qq.com
Status	Not yet recruiting
Phase	Phase 2
Start date	September 2021
Completion date	July 31, 2023

TQB2450 Solution for Injection (TQB2450)+Paclitaxel+Cisplatin ± Anlotinib in the Treatment of Esophageal Cancer.

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms